UBP608 is a potent N-Methyl-D-aspartate receptors (NMDARs) negative allosteric modulator. UBP608 has the potential for the research of neurological disorders.
UBP608 (100 µM) shows inhibitory activity with the inhibition rate of 89.3%, 63.5%, 56.1%, 23.6% for GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C, GluN1/GluN2D, respectively[1].
















